Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Latuda adjunctive to lithium or divalproex in bipolar I depression (PREVAIL3)
NCT01284517Phase 3Completed
- Sponsor
- Sumitomo Pharma America
- Start
- Nov 2010
- Primary completion
- Aug 2012
- Modality
- Small Molecules
- Countries
- 10
01
Overview
A Phase 3 trial of lurasidone in bipolar I disorder, sponsored by Sumitomo Pharma America. Started Nov 2010; status: completed.
02
Drugs
lurasidone
03
Conditions
bipolar I disorder
Beyond the preview
Go deeper on NCT01284517.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01284517.